INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Acute mycoprotein intake decreases insulin levels and reduces energy intake in humans, while its effect on blood glucose remains unclear.

A systematic review evaluated five acute randomised controlled trials with a total of 122 participants to determine the effects of mycoprotein on glycaemic control and energy intake. The results did not show a clear effect of acute mycoprotein on blood glucose levels, but indicated a decrease in insulin levels. Additionally, acute mycoprotein intake decreased energy intake at an ad libitum meal and post-24 h in healthy lean, overweight, and obese humans. The authors noted that evidence comes from a very limited number of heterogeneous studies.

Study type
Systematic review of randomised controlled trials
Who was studied
122 participants across 5 acute studies (healthy lean, overweight, and obese humans)
What was measured
Glycaemic control (glycaemia, insulinaemia) and energy intake

THE PAPER

Effects of mycoprotein on glycaemic control and energy intake in humans: a systematic review.

Cherta-Murillo A, Lett AM, Frampton J, Chambers ES, Finnigan TJA, Frost GS. Br J Nutr, 2020.

PubMed 32100651 ↗DOI 10.1017/s0007114520000756 ↗

Diabetes & blood sugarNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.